Is there a shift from cardiovascular to cancer death in lipid-lowering trials? A systematic review and meta-analysis.

Is there a shift from cardiovascular to cancer death in lipid-lowering trials? A systematic review and meta-analysis.

Show other versions (1)

<h4>Background</h4>Lipid-lowering therapy (LLT) reduces cardiovascular (CV) events, but data are conflicting on all-cause mortality, especially among older adults. Though LLT does not induce cancer, some randomized clinical trials (RCTs) found a pattern of increased cancer death under LL...

Full description

Bibliographic Details
Main Authors: Lucy Bolt, Alexandre Speierer, Sylvain Bétrisey, Martina Aeschbacher-Germann, Manuel R Blum, Baris Gencer, Cinzia Del Giovane, Drahomir Aujseky, Elisavet Moutzouri, Nicolas Rodondi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0297852&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0297852&type=printable

Similar Items